DHR Health Institute for Research and Development Recognized as a “Top Performing Site” Once Again

Community NewsNewsPublisher's Picks
707

Listen to article (english)

Translate to Spanish or other 102 languages!

THREE-PEAT TEAM: The DHR Health Institute for Research and Development pictured here has been recognized as a “Top Performing Site” by SWOG (formerly the Southwest Oncology Group), one of the nation’s leading cancer clinical trials networks. This is the third consecutive time the Institute has received this prestigious recognition. Courtesy image
THREE-PEAT TEAM: The DHR Health Institute for Research and Development pictured here has been recognized as a “Top Performing Site” by SWOG (formerly the Southwest Oncology Group), one of the nation’s leading cancer clinical trials networks. This is the third consecutive time the Institute has received this prestigious recognition. Courtesy image

Mega Doctor News

- Advertisement -

EDINBURG, Texas – The DHR Health Institute for Research and Development is delighted to announce that it has once again been recognized as a “Top Performing Site” by SWOG (formerly the Southwest Oncology Group), one of the nation’s leading cancer clinical trials networks. This marks the third consecutive time the Institute has received this prestigious distinction.

This recognition highlights the ongoing excellence and impact of the Research Institute as it continues to advance cancer research and improve patient outcomes.

“We are deeply honored and this recognition would not be possible without the assistance of the DHR Health Oncology Institute and the leadership of Dr. Jose Cruz,” said Dr. Scott Lillibridge, executive vice president for the DHR Health Institute for Research and Development.

- Advertisement -

SWOG is a global cancer research community supported by the National Cancer Institute (NCI), and recognition as a “Top Performing Site” signifies exceptional performance in clinical trial enrollment, data quality, and patient care standards.

The DHR Health Institute for Research and Development remains committed to innovation and delivering high-quality research opportunities to all residents of the Rio Grande Valley. They are located at 5323 S. McColl Road in Edinburg. For more information about clinical trials in the areas of liver, obesity, cancer, neurology, oncology and urology, call the Institute at (956) 362-2390.

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Combating Vision Loss in the Diabetes Epidemic
Next article
STHS Behavioral to Raise Treatment Age to 13 for Children Requiring Hospitalization

More Articles

Lung Cancer Advances Drive Down Overall Mortality Rates

Cancer death rates fell for both men and women from 2019 to 2023, continuing a downward trend that has lasted more than 20 years, according to the 2026 Annual Report to the Nation on the Status of Cancer, published in the journal Cancer. The continued decline in cancer deaths is driven largely by accelerated progress against lung cancer.

From Classroom to Career: TSC Apprentices Take Next Step Toward Certification

Apprentices in Texas Southmost College’s Early Childhood and Phlebotomy Apprenticeship Programs took an important step toward completing their apprenticeships when they received Occupational Skills Awards (OSA) during a ceremony held September 12 at the ITEC Center. 

STHS Tackles Childhood Asthma in New Episode

If your child frequently experiences coughing, wheezing or shortness of breath, particularly during physical activity, they may be among the millions of young people living with asthma.

McAllen Cancer Survivor Takes Her Fight for Patients to Washington

For breast cancer survivor Elvia Gibbs, traveling from McAllen to Washington, D.C., was about more than advocating for legislation. It was an opportunity to tell lawmakers firsthand that cancer research and access to clinical trials can mean more time, hope, and quality of life for patients.
- Advertisement -